NEUROPREX
NeuroPrex is developing a non-invasive magnetic stimulation device with shield protection and deeper energy delivery for treating major depression and other neurological disorders. Its product will be able to deliver more healing eddy currents to a patient’s disorders with less patient discomfort than other designs. In addition, the cost of the device and treatment cost is expected to be materially lower than for other devices. NeuroPrex wants to change things. The company believes that people deserve better treatment plans than options between a rock and a hard place.
NEUROPREX
Industry:
Health Care Medical Device Neuroscience Wellness
Founded:
2012-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.neuroprexinc.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
280.85 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics Wordpress Plugins
Similar Organizations
Altamira Therapeutics
Altamira Therapeutics develops novel pharmaceutical therapies to prevent and treat severe inner ear disorders.
Cadent Therapeutics
Cadent Therapeutics develops novel medicines that tune and modulate brain rhythms for patients with serious neurological disease.
CeQur
CeQur develops and commercializes insulin delivery systems, giving people with type 2 diabetes freedom from multiple daily injections.
OrCam Technologies
OrCam harnesses the power of artificial vision in an intuitive portable device that compensates for lost visual abilities.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Syrona Health
Syrona Health is a digital health solution for personalised gynaecology across life-stages starting from Endometriosis to Menopause.
Waypoint Orthopedics
Waypoint Orthopedics makes vertebral fixation safer and more efficient for patients, surgeons, and support staff.
Current Employees Featured
Founder
Investors List
National Science Foundation
National Science Foundation investment in Grant - NeuroPrex
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - NeuroPrex
Official Site Inspections
http://www.neuroprexinc.com Semrush global rank: 8.67 M Semrush visits lastest month: 272
- Host name: box2067.bluehost.com
- IP address: 50.87.249.20
- Location: Evanston United States
- Latitude: 42.0311
- Longitude: -87.6858
- Metro Code: 602
- Timezone: America/Chicago
- Postal: 60202
More informations about "NeuroPrex"
Neuroprex Company - Transcranial Magnetic Stimulation
Software Architecture Advisor. Rainer is advising NeuroPrex on software architecture and software systems development. He has a long history of delivering successful solutions for first …See details»
Neuroprex - Transcranial Magnetic Stimulation | TMS Therapy …
NPX is a revolutionary wearable TMS device for treating drug-resistant major depression and PTSD. Patients are stimulated through the proprietary star-shaped electromagnetic coils …See details»
NeuroPrex - Crunchbase Company Profile & Funding
Contact Email [email protected] NeuroPrex is developing a non-invasive magnetic stimulation device with shield protection and deeper energy delivery for treating major …See details»
NeuroPrex Inc. Company Profile | Santa Clara, CA | Competitors ...
Find company research, competitor information, contact details & financial data for NeuroPrex Inc. of Santa Clara, CA. Get the latest business insights from Dun & Bradstreet.See details»
NeuroPrex - Products, Competitors, Financials, Employees, …
Headquarters Location. 2040 Martin Avenue . Santa Clara, California, 95050, United States. 408-688-1707See details»
NeuroPrex - Craft
NeuroPrex has 1 employees at their 1 location and $55.71 k in total funding,. See insights on NeuroPrex including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
Contact - NeuroPrex Inc.
Contact Us NeuroPrex Inc. 2040 Martin Avenue, Santa Clara, CA 95050, USA. Email: [email protected]See details»
Neuroprex, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Neuroprex, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
NeuroPrex - The Org
NeuroPrex develops a non-invasive magnetic stimulation device for treating major depression and other neurological disorders.See details»
Neuroprex, Inc.:Company Profile & Technical Research,Competitor …
Neuroprex, Inc. is a company that provides Neurological disorder, Medical equipment, Neuroscience and more. Neuroprex, Inc. is headquartered in United Kingdom .See details»
Neuroprex - Company Profile - Tracxn
Feb 24, 2025 Neuroprex - Developer of a wearable device to modulate tissue for neurological diseases. Raised a total funding of $50K over 3 rounds from 2 investors. Founded by Janice …See details»
NeuroPrex - Overview, News & Similar companies | ZoomInfo.com
NeuroPrex contact info: Phone number: (408) 688-1707 Website: www.neuroprexinc.com What does NeuroPrex do? NeuroPrex is developing a non-invasive magnetic stimulation device with …See details»
NeuroPrex - Funding, Financials, Valuation & Investors - Crunchbase
NeuroPrex develops a non-invasive magnetic stimulation device for treating major depression and other neurological disorders.See details»
NeuroPrex - Contacts, Employees, Board Members, Advisors
NeuroPrex develops a non-invasive magnetic stimulation device for treating major depression and other neurological disorders.See details»
NeuroPrex - Golden
NeuroPrex is a Santa Clara, California-based company. 2040 Martin Avenue, Santa Clara, CA 95050, USASee details»
News - NeuroPrex Inc.
Santa Clara, California, July 15, 2018 – NeuroPrex Inc. has been awarded a National Science Foundation (NSF) Small Business Innovation…Read more »See details»
Neuroprex - Alien Technology Transfer | Alien Technology Transfer
According to the World Health Organization, depression affects 350 million individuals, 16 million people in the United States only. Depression costs $210 billion a year in lost productivity and …See details»
Competitive Advantage - NeuroPrex Inc.
NSF Award and EC's Seal of Excellence. NeuroPrex received National Science Foundation (NSF) SBIR award in 2018 and Seal of Excellence in 2017-2018 from the European Commission …See details»
Possible New Era in Pain Management: FDA Approves Novel Non …
5 days ago The Institute for Clinical and Economic Review, a nonprofit organization that evaluates prescription drug cost-effectiveness, has suggested that the drug could be only …See details»
Transcranial Magnetic Stimulation Technology - Neuroprex
Transcranial Magnetic Stimulation is changing the landscape of psychiatry by using innovative technology. The TMS device uses a magnetic field to rebalance brain activity. Visit NeuroPrex …See details»